// App-Quantinova.ai

OP0201 (2018) : Clinical outcomes and response to anti-thrombotic treatment among patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicenter cohort study

Researchers

Presenter

  • S. Sciascia

Principal Investigators

  • J. Yazdany

  • M. Cuadrado

  • M. Radin

  • M. Dall’Era

  • I. Aggarwal

  • R. Fenoglio

  • A. Barreca

  • M. Papotti

  • I. Cecchi

  • E. Rubini

  • K. Schreiber

  • D. Roccatello

Medical Centers

  • Center of Research of Immunopathology and Rare Diseases, University of Torino, Torino, Italy

  • UCSF, San Francisco, CA

  • Lupus Unit, GSTT, London, UK

  • University of Turin, Turin, Italy

  • Center of Immunopathology and Rare Diseases, UCSF, San Francisco, USA

  • Psychology, university of Torino, Torino, Italy

Locations

  • Italy

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Nephrology

  • Musculoskeletal

  • Endocrine/metabolic Diseases (ME)

Disease

  • Thrombotic microangiopathy

  • Lupus nephritis

  • Albuminuria

  • Nephritis

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved